Raul C Ribeiro Selected Research

Arabinofuranosylcytosine Triphosphate

1/2018	Comprehensive Ara-C SNP score predicts leukemic cell intracellular ara-CTP levels in pediatric acute myeloid leukemia patients.
10/2002	Interim comparison of a continuous infusion versus a short daily infusion of cytarabine given in combination with cladribine for pediatric acute myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raul C Ribeiro Research Topics

Disease

43	Neoplasms (Cancer) 01/2022 - 03/2003
35	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2022 - 10/2002
30	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 07/2002
29	Leukemia 01/2022 - 07/2002
18	Residual Neoplasm 01/2022 - 01/2004
11	Infections 10/2022 - 08/2003
9	Acute Promyelocytic Leukemia 12/2020 - 03/2013
4	Osteonecrosis (Kienbock's Disease) 01/2020 - 06/2009
3	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 09/2011
3	Carcinogenesis 02/2020 - 06/2010
3	Adrenocortical Carcinoma 02/2020 - 03/2003
3	Thrombosis (Thrombus) 01/2017 - 06/2009
3	Chronic Disease (Chronic Diseases) 04/2015 - 07/2009
3	Burkitt Lymphoma (Burkitt's Lymphoma) 08/2014 - 07/2010
3	Febrile Neutropenia 07/2014 - 01/2010
3	Neutropenia 03/2011 - 07/2008
2	Genomic Instability 01/2022 - 06/2010
2	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 06/2008
2	Pediatric Adrenocortical Carcinoma 01/2021 - 04/2013
2	Exanthema (Rash) 12/2019 - 08/2011
2	Second Primary Neoplasms (Neoplasms, Second) 10/2019 - 08/2003
2	Chromosome Aberrations (Chromosome Abnormalities) 08/2014 - 01/2013
2	Mycoses (Diseases, Fungus) 08/2011 - 07/2008
2	Virilism (Virilization) 05/2011 - 09/2005
2	Hypersensitivity (Allergy) 06/2009 - 09/2005
2	Sepsis (Septicemia) 07/2008 - 09/2003
1	De Lange Syndrome (Cornelia De Lange Syndrome) 01/2022
1	Neuroblastoma 01/2022
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2022
1	Uniparental Disomy 02/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 02/2020
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 02/2020
1	Beckwith-Wiedemann Syndrome (Exomphalos Macroglossia Gigantism Syndrome) 02/2020
1	Adrenocortical Adenoma (Disease, Conn's) 02/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Cardiomyopathies (Cardiomyopathy) 10/2019
1	Acute Megakaryoblastic Leukemia (Leukemia, Megakaryocytic) 01/2019
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2019
1	HIV Infections (HIV Infection) 01/2019

Drug/Important Bio-Agent (IBA)

15	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022 - 10/2002
10	Biological ProductsIBA 10/2020 - 09/2002
7	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 04/2003
7	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2020 - 03/2013
5	Asparaginase (Elspar)FDA Link 01/2022 - 05/2009
5	Clofarabine (Clolar)FDA Link 01/2021 - 08/2011
5	AnthracyclinesIBA 10/2019 - 12/2014
4	Proteins (Proteins, Gene)FDA Link 10/2020 - 03/2011
4	DNA (Deoxyribonucleic Acid)IBA 02/2020 - 01/2004
4	Indicators and Reagents (Reagents)IBA 12/2016 - 07/2002
4	Cladribine FDA LinkGeneric 01/2010 - 10/2002
3	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 08/2011
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 11/2004
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 01/2012
3	Hormones (Hormone)IBA 07/2018 - 09/2005
3	GlucocorticoidsIBA 01/2017 - 05/2009
3	Methotrexate (Mexate)FDA LinkGeneric 03/2014 - 06/2003
3	Messenger RNA (mRNA)IBA 09/2013 - 08/2006
3	Pharmaceutical PreparationsIBA 11/2004 - 12/2003
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 05/2014
2	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 01/2022 - 06/2003
2	triphosphoric acid (triphosphate)IBA 01/2022 - 10/2002
2	AntimetabolitesIBA 01/2021 - 11/2004
2	Hydrocortisone (Cortisol)FDA LinkGeneric 02/2020 - 01/2017
2	fms-Like Tyrosine Kinase 3IBA 11/2019 - 12/2014
2	Daunorubicin (Cerubidine)FDA LinkGeneric 10/2019 - 05/2013
2	Arabinofuranosylcytosine TriphosphateIBA 01/2018 - 10/2002
2	AntibodiesIBA 01/2017 - 11/2008
2	Immunoglobulins (Immunoglobulin)IBA 08/2014 - 01/2009
2	Gemtuzumab (Mylotarg)FDA Link 11/2013 - 03/2013
2	Topotecan (Hycamtin)FDA LinkGeneric 04/2013 - 01/2010
2	Anti-Bacterial Agents (Antibiotics)IBA 07/2008 - 09/2003
2	EnzymesIBA 01/2006 - 03/2003
1	Decitabine FDA Link 07/2022
1	CPX-351IBA 01/2022
1	crenolanibIBA 01/2022
1	Bendamustine Hydrochloride FDA Link 01/2021
1	PanobinostatIBA 11/2020
1	Arsenic Trioxide (Trisenox)FDA Link 10/2020
1	diethylstilbestrol monophosphate (PDES)IBA 02/2020
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 02/2020
1	LipidsIBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020
1	Bevacizumab (Avastin)FDA Link 12/2019
1	Rituximab (Mabthera)FDA Link 01/2019
1	Janus Kinase InhibitorsIBA 01/2019
1	ProdrugsIBA 01/2018

Therapy/Procedure

49	Therapeutics 10/2022 - 08/2002
34	Drug Therapy (Chemotherapy) 01/2022 - 07/2002
15	Remission Induction 07/2022 - 07/2002
5	Cranial Irradiation 12/2019 - 01/2004
5	Radiotherapy 01/2017 - 08/2003
3	Transplantation 08/2011 - 02/2010
2	Aftercare (After-Treatment) 10/2022 - 03/2007
2	Antibiotic Prophylaxis 07/2014 - 07/2008
2	Induction Chemotherapy 05/2014 - 03/2011
2	Combination Drug Therapy (Combination Chemotherapy) 07/2013 - 01/2012
2	Cell Transplantation 07/2012 - 07/2011
2	Central Venous Catheters 05/2012 - 07/2009
2	Catheters 05/2012 - 07/2009
1	Lymph Node Excision (Lymph Node Dissection) 01/2021